Martin Varsavsky on fertility and birth rate decline, gene editing, modern evolution, and why humanity needs more babies.

4 Nov 2025 · 61 min
Episode

4 Nov 2025 · 61 min

0:00

Podcast interview (Oct 2023) with Martin Varsavsky and host Sabrina Halper exploring the fertility crisis, assisted reproductive technologies, gene editing ethics, demographic consequences, and futuristic reproductive/science scenarios. Varsavsky grounds much of his interest in personal experience (7 children; IVF/egg freezing in his family) and entrepreneurship (founded Prelude Fertility, Overture, others). Key claims: infertility mainly stems from delayed childbearing; egg freezing is most effective <35 (35–40 may need multiple cycles); donor eggs enable pregnancy at older ages; embryo selection is legal and widely used in the U.S.; CRISPR germline editing is technically possible but ethically and practically fraught (monogenic vs polygenic traits); cultural/regulatory differences will shape adoption (China more likely to pursue editing). Policy proposals discussed include state-supported childcare (e.g., France's la crèche), custodian voting for parents, and government investment in fertility as long-term taxpayer creation. Varsavsky also touches on longevity, artificial wombs, in vitro gametogenesis, and biosecurity/storage of genetic material.

Questions this episode answers

Seven children, ages 6 to 33.

Any time under 35 is likely to give good results; between 35–40 may require ~3 cycles to match younger results.

Olia Renobables; sold for $1.1 billion (he noted it has since been sold for over $2 billion).

Catastrophic weather: ~60,000/year; air pollution: ~7 million/year; pandemic: ~18 million (global death toll he cited).

Chapters

More from Martin

PodcastEp 4: Martin Varsavsky
Podcast

Ep 4: Martin Varsavsky

11mo ago
PodcastMartin Varsavsky on How U.S. Tech Firms Differ from Their European Counterparts
Podcast

Martin Varsavsky on How U.S. Tech Firms Differ from Their European Counterparts

19y ago
See all content